Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sharon Shacham currently holds 20,275 shares of Acrivon Therapeutics, Inc. (ACRV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sharon Shacham has been a net seller of ACRV stock. They have purchased $0 and sold $20.7M worth of shares.
Sharon Shacham's most recent insider trade was on Jun 20, 2024, when they sold 20,275 shares at $0.00 per share.
Sharon Shacham serves as Executive at Acrivon Therapeutics, Inc. (ACRV). They have executed 161 insider transactions totaling $20.7M over their tenure at the company.
Sharon Shacham holds the position of Executive at Acrivon Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Sharon Shacham has shown a selling trading pattern, with $0 in total purchases and $20.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Sharon Shacham was on Jun 22, 2020, when they sold $150.0K worth of KPTI shares. This transaction involved 7,500 shares at $20.00 per share.
Sharon Shacham currently owns 20,275 shares of Acrivon Therapeutics, Inc. (ACRV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sharon Shacham's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sharon Shacham has 161 Form 4 filings on record as an insider at Acrivon Therapeutics, Inc..
Set alerts for Sharon Shacham and 40,000+ other insiders.